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Abstract
Background: To estimate the prevalence of minor depression among US adults with diabetes,
health care resource utilization, and expenditures by people with diabetes with and without minor
depression.
Methods:  Among adult 2003 Medical Expenditure Panel Survey respondents, diabetes was
identified by diagnosis code and self-report. Depression was identified by diagnosis code plus ≥ one
antidepressant prescription. Odds of having depression was estimated in people with diabetes and
the general population, adjusted for sociodemographic variables (e.g., age, sex, race/ethnicity).
Multivariate regressions evaluated factors associated with utilization and log-transformed
expenditures for ambulatory care, hospitalizations, emergency visits, and prescriptions.
Results: In 2003, 1932 respondents had diabetes, 435/1932 had diabetes and minor depression.
Adults with diabetes were more likely than the general population to have depression (adjusted
OR 1.81, 95% CI 1.56, 2.09). People with diabetes with versus without comorbid depression were
more likely to be women, have lower incomes and health status, and more diabetes complications
(all p < 0.05). In unadjusted analyses, ambulatory care visits were higher for those with versus
without depression (17.9 vs. 11.4, p = 0.04), as were prescriptions (60.7 vs. 38.1, p = 0.05). In
adjusted analyses, depression was not associated with increased resource use or higher
expenditures in any category. Increased number of comorbid conditions was associated with
increased resource use in all categories, and increased expenditures for ambulatory care and
prescriptions.
Conclusion: People with diabetes are twice as likely to have depression as the general population.
Screening for and treatment of depression is warranted, as is additional research into a causal
relationship between diabetes and depression.
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Background
Diabetes and depression are costly chronic medical condi-
tions, suffered by millions of Americans every year. The
American Diabetes Association estimates that 20.8 mil-
lion people had diabetes in 2005.[1] In 2002, total expen-
ditures for people with diabetes in the U.S. (including all
inpatient care, outpatient care and pharmaceuticals for all
health conditions – not only diabetes care) were esti-
mated to be nearly $132 billion.[2] In 2000 the preva-
lence of depression in the United States was between 5
and 10.3 percent of the population, affecting more than
19 million Americans each year.[3] The economic burden
of depression in 2002 was estimated at $83.1 billion.[4,5]
Co-occurrence of these two illnesses is prevalent in the
United States. People with diabetes are approximately 2.5
times more likely to be diagnosed with depression than
those without diabetes. [6-8] Temporal or causal relation-
ships between the two conditions remain unclear but
under study.
Health care expenditures and utilization among individu-
als with diabetes and comorbid depression warrant addi-
tional research for a number of reasons. Depressed
patients with a chronic illness are less likely to follow a
recommended health or medication regimen.[9] Depres-
sive symptoms are associated with a perception of more
impaired physical health and may mimic worsening dia-
betes symptoms.[9] Poor glucose control is associated
with depression and effective treatment of depression may
improve diabetes control.[10]
Previous studies evaluating health care expenditures and
utilization associated with diabetes and comorbid depres-
sion report that in regional or selected populations,
comorbid diabetes and depression are associated with
more health care utilization and expenditures than diabe-
tes without depression.[9,11,12] The most recent study
estimating odds of diagnosed depression in individuals
with diabetes and relationships between depression and
health care utilization and expenditures in a nationally
representative database was performed using 1996 data
from the Medical Expenditure Panel Survey (MEPS). We
propose to update that analysis, and hypothesize, based
on recent drug developments in both diabetes manage-
ment and treatment of depression, that individuals with
both diabetes and minor depression will have higher rates
of health care utilization in four categories: ambulatory
care, inpatient care, emergency department visits, and pre-
scription medications. While an increase in health care
utilization often predicts a proportionate increase in
expenditures, this may not hold true due to improved
overall health resulting from effective treatment. There-
fore, expenditures in all four categories will also be exam-
ined for US adults with diabetes with and without minor
depression.
Methods
Data Source
Study subjects were respondents in the 2003 MEPS data-
base. MEPS is cosponsored by the Agency for Healthcare
Research and Quality (AHRQ) and the National Center
for Health Statistics and is representative of the US non-
institutionalized civilian population.[13] MEPS uses sam-
pling weights reflecting adjustments for survey non-
response and population totals from the Current Popula-
tion Survey.[13] As a result, MEPS weights were applied in
all analyses to obtain nationally representative estimates.
Case Definition for Study Subjects
The study cases were defined as individuals with diabetes
with and without comorbid depression, identified using
International Classification of Diseases, Ninth Revision, Clin-
ical Modification (ICD-9-CM) codes. MEPS uses three digit
(less specific) ICD-9-CM codes rather than five digit codes
in order to protect respondent confidentiality. ICD-9-CM
code 250, Diabetes Mellitus, was used to identify people
with diabetes. Diabetes was also identified using patient
self-report in answer to survey questions asking if
respondents had ever been diagnosed with or told they
have diabetes. The case definition for minor depression
required a record of ICD-9 code 311 (Depression NOS),
plus a prescription for an antidepressant medication.
When determining the odds of having comorbid depres-
sion, the cohort of individuals with diabetes was com-
pared with all of the MEPS survey respondents for the
entire year.
Definition of Health Care Utilization and Expenditures
Four categories of health care utilization and expenditures
were examined: 1) ambulatory care (including visits with
a medical provider visits in an office or outpatient set-
ting), 2) inpatient care (number of hospital admissions
including zero-day stays), 3) emergency department visits,
and 4) prescription medications received. Expenditures in
MEPS are defined as the sum of payments for care, not
charges or resource costs. Expenditure data include out-of-
pocket payments, third-party payer payments (including
Medicare, Medicaid and private insurance) and amounts
for services rendered by public providers (including
Department of Veterans Affairs Medical Centers). Alterna-
tive care services and over-the-counter medications are
not included in MEPS total expenditures. In cases where
expenditure data are missing or where care is provided
under a capitated reimbursement arrangement, MEPS
uses an imputation process to estimate expenditures. The
process, known as the "hot-deck" method, involves
matching the medical event for which expenditure data
are missing with an event that has similar characteris-Cost Effectiveness and Resource Allocation 2007, 5:4 http://www.resource-allocation.com/content/5/1/4
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tics.[14] The amount of expenditures for the similar event
is then assigned to the missing data.
Data Analysis
Population characteristics were examined for differences
between individuals with diabetes with and without
depression using chi-square or t-tests as appropriate.
Characteristics included age, sex, race/ethnicity, level of
education, health insurance status, number of comorbid-
ities (based on number of unique ICD-9 codes[15]), pov-
erty level, physical and mental health status, and diabetes
severity. Physical and mental health status were based on
the Short-Form 12 survey's Physical and Mental Compo-
nent Summary scores (SF-12 PCS and SF-12 MCS).[16]
Proxy measures for diabetes severity were the presence of
coronary heart disease (CHD), diabetes-related eye prob-
lems, or diabetes-related kidney problems, or use of insu-
lin.
The prevalence of having depression in individuals with
diabetes versus the general population was determined
using unadjusted chi-square analysis as well as analyses
adjusting for age, sex, race/ethnicity and marital status.
Mean, unadjusted annual utilization rates and expendi-
tures for ambulatory care visits, inpatient admissions,
emergency department visits, and prescription medica-
tions were estimated in univariate analyses. Due to their
skewed nature, expenditure data were log transformed
prior to testing for statistical significance.
Multivariate regression methods for survey data were used
to identify those factors that were significantly associated
with resource use and log-transformed expenditures in
each category. All expenditure data were expressed in
2003 US$. Resource utilization data are discrete data in
that an individual can have one or two office visits, but
not 1.5. In addition, many respondents have a low
number of visits (e.g., zero or one), while a few people
have many visits. Due to this over-dispersion of data and
the fact that the data are discrete, negative binomial
regression methods were used to evaluate predictors of
health care utilization. Linear regression methods were
used to evaluate predictors of log-transformed expendi-
tures. For both utilization and expenditures, the predictor
variable of interest was the presence or absence of diag-
nosed minor depression. Covariates in both models
included age, sex, years of education, race/ethnicity,
income level, insurance status, number of comorbid con-
ditions, presence of diabetes complications, use of insu-
lin, having a usual source of care, and physical and mental
health status were included in the models. STATA Statisti-
cal Software was used in order to account for the MEPS
survey weights and to provide nationally representative
estimates. All differences between estimates were consid-
ered statistically significant at the p = 0.05 level. The Colo-
rado Multiple Institutional Review Board approved this
study.
Results
A total of 1932 US adults with diabetes were identified,
435 with minor depression and 1497 without minor
depression. Individuals with diabetes were significantly
more likely to have depression than were people without
diabetes (OR 2.47, 95% CI 2.17, 2.81). After adjusting for
age, sex, race/ethnicity and marital status, individuals
with diabetes remained almost twice as likely as individu-
als without diabetes to have depression (OR 1.81, C.I.
1.56–2.09).
A higher proportion of women than men were depressed
(65% vs. 35%, p < 0.05). Compared to adults without
depression, those with depression had lower incomes,
more comorbid conditions (10.2 vs. 6.5, p < 0.05), and
were more likely to use insulin (18.7% vs. 7.3%, p < 0.01).
Depressed individuals were also more likely to have dia-
betes-related complications than those without depres-
sion (Table 1). Physical and mental health status was also
higher for adults without depression compared to those
with depression (41.1 vs. 35.4, p < 0.01 and 50.4 vs. 40.6,
p < 0.05, respectively).
Mean, unadjusted annual health care utilization rates and
expenditures for 2003 are presented in Table 2. Depressed
individuals had significantly more ambulatory care visits
(17.9 vs. 11.4, p = 0.04) and more prescriptions (60.7 vs.
37.8, p = 0.05) than non-depressed individuals. Mean
number of emergency department visits were higher for
those with depression, with borderline significance (0.51
vs 0.31, p = 0.053). Differences between utilization rates
did not reach statistical significance in any other category
of care.
Multivariate regression results identifying factors associ-
ated with resource use and log-transformed expenditures
are shown in Tables 3 and 4, respectively. In adjusted
analyses, comorbid minor depression was not signifi-
cantly associated with resource utilization or expenditures
in any category, including total expenditures (data not
shown). Factors significantly associated with utilization in
adjusted regressions were education (ambulatory care),
race/ethnicity (prescriptions), income (prescriptions),
having a usual source of care (hospitalizations), comor-
bidities (all four categories), CHD diagnosis (prescrip-
tions), insulin use (hospitalizations and prescriptions),
physical health status (emergency visits and prescrip-
tions), and mental health status (hospitalizations, emer-
gency visits, and prescriptions). Factors significantly
associated with expenditures in fully adjusted models
were age (emergency visits and prescriptions), sex and
education (ambulatory care), race/ethnicity (prescrip-Cost Effectiveness and Resource Allocation 2007, 5:4 http://www.resource-allocation.com/content/5/1/4
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tions), income (ambulatory care), insurance (emergency
visits and hospitalizations), number of comorbidities
(ambulatory care and prescriptions), diabetes-related eye
problems (emergency visits and hospitalizations), insulin
use (prescriptions), and physical health status (prescrip-
tions). Insurance status, number of comorbidities, physi-
cal health status, and insulin use were significantly
associated with higher total expenditures (data not
shown).
Discussion
US adults with diabetes were nearly twice as likely to have
minor depression compared with the general population
in 2003. These results are consistent with previous reports
of increased depression prevalence among those with dia-
betes. In a meta-analysis of 42 eligible studies, 18
included a non-diabetic control group and provided data
sufficient to calculate a pooled odds ratio.[8] Results of
that study indicated that among people with diabetes, the
odds of having depression were twice that of those with-
out diabetes. The finding in the current study of an
increased prevalence of minor depression among people
with diabetes in a nationally representative database rein-
forces the need to consider comorbid depression when
treating patients with diabetes for a number of reasons.
First, comorbid depression in people with diabetes has
been associated with poor glycemic control. Lustman and
colleagues report, also based on a meta-analysis, that
Table 1: Demographic and clinical characteristics of Adults with diabetes with and without comorbid depression. (United States, 
2003)
Variable Depression +
n = 435
Depression - 
n = 1497
Age (mean, SE) 59.0 (0.35) 61.0 (0.62)
Sex (% male, SE) 35 (0.02) 51 (0.02)*
Education (mean years, SE) 11.6 (0.13) 11.8 (0.11)
Race/Ethnicity (%, SE)
Hispanic 11 (0.04) 12 (0.04)
Black, not Hispanic 13 (0.01) 16 (0.01)
Asian, not Hispanic 1 (0.02) 5 (0.02)
White and other 75 (0.02) 67 (0.01)
Income level (%, SE)
Poor (< 100% federal poverty level (fpl)) 20 (0.03) 12 (0.03)*
Near poor (100–124% fpl) 7 (0.04) 6 (0.04)*
Low income (125–199% fpl) 17 (0.02) 17 (0.02)*
Middle income (200–399% fpl) 33 (0.02) 30 (0.02)*
High income (> 400% fpl) 23 (0.01) 35 (0.01)*
Insurance coverage (%, SE)
Private only 59 (0.01) 64 (0.01)
Public only 36 (0.01) 29 (0.01)
None 5 (0.04) 7 (0.04)
Having a Usual Source of Care (%, SE) 96 (0.04) 95 (0.03)
# of Comorbid conditions (mean, SE) 10.2 (0.43) 6.5 (0.07)*
Diabetes complications (% yes, SE)
CHD 4.0 (0.01) 12.1 (0.01)*
Eye 7.5 (0.02) 18.6 (0.02)†
Renal 11.3 (0.04) 20.0 (0.04)†
Insulin use (% yes, SE) 7.3 (0.03) 18.7 (0.03)†
Health Status
SF-12 PCS (mean, SE) 35.4 (0.42) 41.1 (0.25)†
SF-12 MCS (mean, SE) 40.6 (1.04) 50.4 (0.17)*
* = p < 0.05; † = p < 0.01Cost Effectiveness and Resource Allocation 2007, 5:4 http://www.resource-allocation.com/content/5/1/4
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adults with diabetes and depression were more likely to
have elevated glycosylated hemoglobin (HbA1c) than
those without depression.[10] Results of increased HbA1c
for diabetes with compared to without depression were
consistent for both type1 and 2 diabetes, and for depres-
sion assessed by self-report and diagnosis codes. A
number of studies suggest that the mechanism for poorer
glycemic control among those with diabetes with versus
without depression may be related to the impact of
depression on self-care activities. Depression and diabetes
is associated with poorer adherence to medication, diet,
and exercise regimens.[9,17,18]
Secondly, an association between comorbid depression
and diabetes and increased mortality has been proposed
in a number of studies. Katon, et al, reported that younger
age is associated with major depression among people
with diabetes receiving care through a managed care
organization in Washington state.[19] Similar results have
been reported for patients with minor depression and dia-
betes using data from the Medical Expenditure Panel Sur-
vey.[20] Finally, Zhang demonstrated an increased risk for
mortality among people with versus without major
depressive symptoms based on analyses using the
National Health and Nutrition Examination Survey.[21]
Together, these results present a compelling need to
screen for, diagnose, and effectively treat depression
among people with diabetes. Screening for depressive
symptoms could be incorporated into patient care activi-
ties with screening tools. One such instrument is the
PHQ-2, a validated 2 question screen that can identify
patients with diabetes that may benefit from further eval-
uation for comorbid depression. [22-24]
In adjusted analyses, no significant associations exist
between comorbid depression and total expenditures,
expenditures in any category, or resource utilization in
any category. An increased number of comorbid condi-
tions were associated with increased utilization in all four
categories. Health status was associated with hospitaliza-
tions, emergency visits, and prescription use. Higher levels
of physical functioning were associated with decreased
use of emergency visits and prescriptions, while higher
mental functioning was associated with decreased use in
all categories except ambulatory care visits. Increased pre-
scription use was associated with being white (not His-
panic) compared to Hispanic ethnicity. Being near poor
or having high income were both associated with
decreased use of prescription medications compared to
the lowest income category. Because use of prescription
medications requires access to physician services, the
potential exists that those in the near poor category have
difficulty either seeing a prescribing health provider and/
or affording the out-of-pocket costs of medications. Those
in the highest income category may be in overall better
health. These issues warrant further study.
In adjusted analyses evaluating factors associated with
expenditures, an increased number of comorbid condi-
tions was associated with increased expenditures for
ambulatory visits and prescription medications. Having
public only or no insurance was associated with lower
expenditures for inpatient and emergency care. No other
consistent associations were observed between covariates
and expenditures in more than one category.
These results differ from those previously reported from
the 1996 MEPS data,[6] perhaps due to the fact that our
analyses adjusted for more covariates. The earlier reported
analyses adjusted for age, sex, race/ethnicity, health insur-
ance, and number (ranging from one to seven) of comor-
bid chronic conditions.[6] Multivariate regressions in the
current study adjusted for additional variables including
education, income, the presence of diabetes-related com-
plications, and physical and mental health status. Varia-
bles relating to diabetes-related complications and health
status were not available in the 1996 MEPS database. Fac-
tors that were significant predictors of total costs for US
Table 2: Mean unadjusted annual health care utilization and expenditures among US adults with diabetes with and without minor 
depression
Utilization* Expenditures†
Category DEP + DEP - DEP + DEP -
Ambulatory Care 17.9 11.4‡ $2,297 $1,420
Hospitalizations 0.53 0.28 $4,390 $2,684
Emergency Department Visits 0.51 0.31 $294 $166
Prescriptions 60.7 37.8‡ $4,061 $2,374
Total n/a n/a $13,038 $8,065
* Mean units of use
† Expressed as 2003 US$
‡ = p ≤ 0.05Cost Effectiveness and Resource Allocation 2007, 5:4 http://www.resource-allocation.com/content/5/1/4
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adults with diabetes in 2003 were insurance status,
number of comorbidities, physical health status, and
insulin use.
US adults with diabetes are twice as likely to have comor-
bid minor depression as US adults without diabetes. As
discussed earlier, comorbid depression has a deleterious
impact on adherence to medication and medical regi-
mens, and is associated with poor glycemic control.
Ongoing research is necessary to elucidate both the causal
relationship between diabetes and depression, as well as
identify interventions to treat depression effectively in
adults with diabetes. The American Diabetes Association
recommends that all factors, clinical as well as psychoso-
cial, should be considered when developing treatment
plans for people with diabetes.[25] Screening for and
treating depression in the diabetes population is an
important component of care for the whole patient.
Another area warranting additional research is the poten-
tial that the association between depression and glycemic
control is mediated through the deleterious impact of
depression on self-care behaviors. As discussed earlier,
depression among people with diabetes is associated with
poor self-care behaviors. Improving self-care behaviors
has been shown to improve glycemic control, supporting
the need for ongoing research to confirm the links
between depression, diabetes self-management, and glyc-
Table 3: Factors associated with health care utilization by category by US adults with diabetes, 2003
Ambulatory Care Hospitalizations Emergency Visits Prescriptions
Variable β Coeff 95% CI β Coeff 95% CI β Coeff 95% CI β Coeff 95% CI
Depression -0.02 -0.17, 0.12 -0.19 -0.73, 0.34 -0.014 -1.18, 0.90 0.09 -0.16, 0.34
Age 0.002 -0.005, 0.01 0.02 -0.01, 0.04 -0.002 -0.02, 0.02 0.003 -0.001, 0.01
Sex 0.05 -0.10, 0.19 -0.15 -0.94, 0.63 0.11 -0.24, 0.46 0.01 -0.02, 0.04
Years of Education 0.04 0.03, 0.04 † -0.04 -0.12, -0.05 -0.02 -0.14, 0.11 -0.002 -0.03, 0.02
Race/Ethnicity
Black, not Hispanic -0.09 -0.36, 0.17 0.26 -0.46, 0.98 0.20 -0.37, 0.77 0.27 -0.06, 0.60
Asian, not Hispanic -0.01 -0.017, 0.14 -0.09 -1.13, 0.96 -0.06 -1.61, 1.48 0.15 -0.07, 0.36
White/Other, not Hispanic -0.01 -0.020, 0.18 0.23 -1.20, 1.65 0.05 -0.86, 0.95 0.25 0.02, 0.48*
Income level
Near poor -0.33 -0.73, 0.07 -0.18 -1.85, 1.49 -0.46 -2.40, 1.49 -0.37 -0.61, -0.14*
Low Income -0.10 -0.53, 0.33 -0.11 -0.34, 0.12 0.002 -0.35, 0.36 -0.11 -0.63, 0.40
Middle Income -0.09 -0.51, 0.33 -0.18 -1.14, 0.77 -0.27 -1.24, 0.70 -0.09 -0.30, 0.11
High Income -0.014 -0.59, 0.31 -0.38 -1.39, 0.64 -0.50 -1.67, 0.68 -0.14 -0.26, -0.01*
Insurance status
Public only -0.14 -0.54, 0.25 -0.20 -0.42, -0.01 -0.10 -1.47, 1.26 0.14 -0.12, 0.40
No insurance -0.38 -1.71, 0.96 -0.37 -1.75, 1.00 -0.24 -1.51, 1.02 -0.14 -0.51, 0.23
Have usual source of care -0.22 -1.44, 1.00 0.74 0.59, 0.90† 0.31 -0.87, 1.49 -0.44 -0.81, -0.06
# of Comorbid conditions 0.08 0.05, 0.12 † 0.12 0.09, 0.15† 0.08 0.04, 0.11* 0.06 0.04, 0.08†
DM complications
CHD 0.04 -0.18, 0.27 -0.02 -0.15, 0.12 0.16 -0.18, 0.50 -0.12 -0.21, -0.03*
Eye 0.06 -0.24, 0.36 0.05 -0.30, 0.41 -0.08 -0.39, 0.22 -0.05 -0.11, 0.01
Renal 0.00 -0.83, 0.84 -0.10 -1.17, 0.96 -0.03 -0.53, 0.47 -0.01 -0.10, 0.07
Insulin use 0.07 -0.04, 0.17 -0.40 -0.68, -0.11* -0.33 -0.95, 0.28 -0.16 -0.28, -0.05*
SF-12 PCS -0.01 -0.02, 0.008 -0.01 -0.04, 0.01 -0.01 -0.03, -0.0003* -0.01 -0.01, -0.005†
SF-12 MCS -0.004 -0.01, 0.004 -0.019 -0.023, -0.016† -0.01 -0.03, -0.001* -0.001 -0.002, 0.001*
* = p < 0.05; † = p < 0.01; ‡ = p < 0.001
Reference groups: no depression, female, race/ethnicity = Hispanic, income level = poor, private insurance, no usual source of care, no CHD, no 
eye disease, no renal disease, no insulin use Abbreviations: DM = diabetes mellitus; SF-12 PCS = Short From 12 Physical Component Summary; SF-
12 MCS = SF-12 Mental Component Summary; CHD = coronary heart diseaseCost Effectiveness and Resource Allocation 2007, 5:4 http://www.resource-allocation.com/content/5/1/4
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emic control, as well as research to investigate whether
interventions treating depression can improve self-care
and glycemic control.
In addition to providing a basis for future research, there
are several strengths of this study. The MEPS database is a
large, nationally representative sample of the United
States civilian non-institutionalized population, with an
over-sampling of black and Hispanic subpopulations. The
results are generalizable and the study was able to incor-
porate appropriate adjustments for demographic charac-
teristics, such as age, sex, and race/ethnicity, as well as
clinical characteristics, such as number of comorbidities.
The potential exists for underreporting of either diabetes
or depression in the MEPS database, either of which
would have limited the sample size of this study. A diag-
nosis of depression is particularly vulnerable to this limi-
tation due to under-diagnosing and potential stigma that
may be attached to mental disorders. The case definition
for minor depression used in the current study required a
diagnosis code and use of a prescription antidepressant,
cases included here are likely to be accurately assessed as
being depressed. A potential limitation of this restrictive
case definition is that individuals with undiagnosed
depression, as well as those with a diagnosis but without
treatment with prescription medication will be misclassi-
Table 4: Factors associated with health care expenditures by adults with diabetes in 2003.*
Ambulatory Care Hospitalizations Emergency Visits Prescriptions
Variable β Coeff 95% CI β Coeff 95% CI β Coeff 95% CI β Coeff 95% CI
Depression 0.01 -0.06, 0.05 -0.02 -0.15, 0.10 0.04 -0.48, 0.57 0.10 -0.02, 0.23
Age 0.002 -0.005, 0.01 0.01 -0.02, 0.03 -0.01 -0.01, -0.003† 0.002 0.000, 0.005†
Sex -0.03 -0.06, 0.01† -0.10 -0.33, 0.12 -0.11 -0.44, 0.23 -0.05 -0.15, 0.06
Years of Education 0.02 0.00, 0.05† 0.005 -0.01, 0.02 -0.02 -0.06, 0.01 0.002 -0.01, 0.02
Race/Ethnicity
Black, not Hispanic -0.07 -0.18, 0.04 0.27 -0.20, 0.73 -0.01 -0.24, 0.22 0.13 -0.01, 0.28
Asian, not Hispanic 0.01 -0.41, 0.42 -0.09 -1.27, 1.09 0.45 -0.48, 1.38 0.12 -0.23, 0.47
White/Other, not Hispanic 0.001 -0.25, 0.25 0.04 -0.30, 0.39 0.04 -0.20, 0.28 0.15 0.06, 0.24†
Income level
Near poor -0.11 -0.22, 0.004 0.20 -0.19, 0.59 0.08 -0.20, 0.35 -0.13 -0.33, 0.07
Low Income -0.11 -0.20, -0.01† 0.11 -0.06, 0.29 0.21 -0.52, 0.94 -0.07 -0.21, 0.07
Middle Income 0.02 -0.09, 0.13 0.04 -0.09, 1.70 0.11 -0.27, 0.49 -0.04 -0.26, 0.18
High Income -0.06 -0.12, 0.00† -0.05 -0.36, 0.27 0.08 -0.57, 0.72 -0.06 -0.19, 0.08
Insurance status
public only -0.09 -0.25, 0.07 -0.15 -0.22, -0.08† -0.14 -0.28, -0.003† 0.06 -0.20, 0.32
no insurance -0.26 -0.78, 0.26 -0.56 -0.96, -0.14† -0.36 -0.51, -0.20‡ -0.06 -0.43, 0.30
Have usual source of care -0.08 -0.81, 0.66 -0.22 -0.96, 0.52 0.35 -0.40, 1.10 -0.11 -0.43, 0.22
# of Comorbid conditions 0.06 0.05, 0.06‡ 0.01 -0.01, 0.03 0.01 -0.04, 0.05 0.04 0.03, 0.04§
DM complications
CHD -0.02 -0.16, 0.12 -0.03 -0.09, 0.03 0.06 -0.53, 0.65 -0.06 -0.15, 0.04
Eye 0.02 -0.01, 0.05 0.11 0.01, 0.21† -0.13 -0.17, -0.08‡ -0.04 -0.16, 0.19
Renal -0.04 -0.42, 0.34 -0.08 -0.19, 0.02 -0.06 -0.71, 0.58 0.004 -0.12, 0.13
Insulin use -0.01 -0.10, 0.07 -0.19 -0.54, 0.15 0.09 -0.13, 0.30 -0.13 -0.19, -0.07†
SF-12 PCS -0.002 -0.01, 0.01 0.0007 -0.002, 0.003 -0.003 -0.01, 0.001 -0.004 -0.01, -0.0001†
SF-12 MCS -0.002 -0.01, 0.004 0.002 -0.01, 0.01 0.001 -0.01, 0.01 0.0002 -0.004, 0.004
* Expenditures log transformed to account for skewed data
† = p < 0.05; ‡ = p < 0.01; § = p < 0.001
Reference groups: no depression, female, race/ethnicity = Hispanic, income level = poor, private insurance, no usual source of care, no CHD, no 
Eye disease, no renal disease, no insulin use Abbreviations: ; SF-12 PCS = Short From 12 Physical Component Summary; SF-12 MCS: SF-12 Mental 
Component Summary; CHD = coronary heart diseaseCost Effectiveness and Resource Allocation 2007, 5:4 http://www.resource-allocation.com/content/5/1/4
Page 8 of 8
(page number not for citation purposes)
fied as having diabetes without depression. The 2003
MEPS database does not include data obtained by screen-
ing respondents for depressive symptoms, which may be
a limitation of these analyses. However, we report preva-
lence estimates for comorbid depression consistent with
published studies, despite the potential for misclassifica-
tion. A further source of misclassification in this study is
the inclusion of adults with diabetes with major depres-
sion in the non-depressed (i.e., depression -) group. Based
on a post-hoc analysis, only 19 individuals had diagnosis
codes for diabetes and major depression in the 2003
MEPS database. Therefore, the impact of any misclassifica-
tion of respondents with major depression is likely to be
minimal. Finally, MEPS includes only 3-digit ICD-9
codes, preventing a classification of Type 1 or Type 2 dia-
betes. Due to the relatively low prevalence of Type 1 dia-
betes (5–10% of all people with diabetes), the impact of
this limitation is expected to be minimal.[1]
Conclusion
People with diabetes are twice as likely to be depressed as
the general population, a factor to be considered when
developing diabetes treatment programs. Screening for
and treatment of depression is appropriate, as is addi-
tional research into a causal relationship between diabetes
and depression.
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